mph Bangladesh


(i pra troe' pee um)

P  - Caution when used during pregnancy

L  - Caution when used during lactation

Molecule Info

Indication & Dosage


Seasonal allergic rhinitis, Adult: As metered-dose nasal spray (0.06%): 42 mcg into each nostril bid/tid, up to 84 mcg into each nostril 3-4 times daily for up to 4 days when rhinorrhea is associated with common cold or up to 3 wk in seasonal allergic cases. Child: As metered-dose nasal spray: ≥6 yr: 42 mcg into each nostril bid/tid.


Rhinorrhoea associated with rhinitis, Adult: As metered-dose nasal spray (0.06%): 42 mcg into each nostril bid/tid, up to 84 mcg into each nostril 3-4 times daily for up to 4 days when rhinorrhoea is associated with common cold or up to 3 wk in seasonal allergic cases. Child: As metered-dose nasal spray: ≥6 yr: 42 mcg into each nostril bid/tid.


Chronic obstructive pulmonary disease, Adult: As metered-dose aerosol: 20 or 40 mcg 3 or 4 times daily. Max: 12 inhalations daily. As dry powder: 40 mcg 3 or 4 times daily. Max: 320 mcg daily. As nebulised solution: 500 mcg (1 unit dose vial) 3-4 times daily. Child: As metered-dose aerosol: <6 yr: 20 mcg tid; 6-12 yr: 20 or 40 mcg tid. As nebulised solution: <6 yr: 125-250 mcg; 6-12 yr: 250 mcg at intervals of at least 6 hr up to 1mg daily.


May be taken with or without food.

Special Precautions

Bladder neck obstruction, narrow-angle glaucoma or patients susceptible to glaucoma, prostatic hyperplasia. Protect patient's eyes from nebulised drug. Renal and hepatic impairment. Pregnancy, lactation, children, elderly.

Adverse Drug Reactions

Dry mouth, urinary retention, buccal ulceration, paralytic ileus, headache, nausea, constipation, paradoxical bronchospasm, immediate hypersensitivity reactions (urticaria, angioedema), acute angle-closure glaucoma, nasal dryness and epistaxis . Potentially Fatal: Anaphylactic reactions, atrial fibrillation, supraventricular tachycardia.

Drug Interactions

Increased toxicity with other anticholinergic drugs. ipratropium bromide Drug Interactions

Pregnancy Category

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect  that was not confirmed in controlled studies in women in the 1sttrimester .


Inhalation: Aerosol: Store at 25°C . Do not expose above 49°C . Solution: Store at 15-30°C . Nasal: Store tightly closed at 25°C .


Ipratropium bromide blocks the action of acetylcholine at parasympathetic sites in bronchial smooth muscle causing bronchodilation. Absorption: Poorly absorbed from the GIT. Distribution: Minimally protein-bound. Excretion: Via urine and faeces .

ATC Classification

R03BB01 - ipratropium bromide; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, anticholinergics. R01AX03 - ipratropium bromide; Belongs to the class of other topical preparations used as nasal decongestants.

Brand/Product Info

Total Products : 6      
Brand Name Manufacturer/Marketer Composition Dosage Form Pack Size & Price
G-IPRA Gonoshasthaya Pharmaceuticals Ltd Ipratropium bromide 250mcg/ml Respiratory Solution 20ml vial: 60.25 MRP
IPRAMID HFA Beximco Pharmaceuticals Ltd Ipratropium Bromide BP 20mcg Per Actuation Inhaler 200 MD: 200.00 MRP
IPRAMID SOLUTION Beximco Pharmaceuticals Ltd Ipratropium Bromide BP Solution 20ml Solution 20ml: 130.00 MRP
Ipratop Incepta Pharmaceuticals Limited Ipratropium Bromide BP 250 mcg/ml Nebuliser Solution 20ml:MRP 130 Tk
IPREX HFA Square Pharmaceuticals Ltd. Ipratropium Bromide 20 mcg/puff HFA Inhaler (CFC-Free) 200 puffs: 250.75 MRP
IPREX RESP Square Pharmaceuticals Ltd. Ipratropium Bromide 250 mcg/ml Respirator Solution 20 ml: 130.88 MRP

Gen. MedInfo

Why is this medication prescribed?

Ipratropium oral inhalation is used to prevent wheezing, shortness of breath, coughing, and chest tightness in people with chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways) such as chronic bronchitis (swelling of the air passages that lead to the lungs) and emphysema (damage to the air sacs in the lungs). Ipratropium is in a class of medications called bronchodilators. It works by relaxing and opening the air passages to the lungs to make breathing easier.

How should this medicine be used?

Ipratropium may come as a solution (liquid) to inhale by mouth using a nebulizer (machine that turns medication into a mist that can be inhaled) and as an aerosol to inhale by mouth using an inhaler. The nebulizer solution is usually used three or four times a day, once every 6 to 8 hours. The aerosol is usually used four times a day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use ipratropium exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.

Talk to your doctor about what you should do if you experience symptoms such as wheezing, difficulty breathing, or chest tightness. Your doctor will probably give you a different inhaler that acts more quickly than ipratropium to relieve these symptoms. Your doctor may also tell you to use additional puffs of ipratropium along with other medications to treat these symptoms. Follow these directions carefully and be sure you know when you should use each of your inhalers. Do not use extra puffs of ipratropium unless your doctor tells you that you should. Never use more than 12 puffs of ipratropium inhalation aerosol in a 24-hour period.

Call your doctor if your symptoms worsen or if you feel that ipratropium inhalation no longer controls your symptoms. Also call your doctor if you were told to use extra doses of ipratropium and you find that you need to use more doses than usual.

If you are using the inhaler, your medication will come in canisters. Each canister of ipratropium aerosol is designed to provide 200 inhalations. After the labeled number of inhalations has been used, later inhalations may not contain the correct amount of medication. You should keep track of the number of inhalations you have used. You can divide the number of inhalations in your inhaler by the number of inhalations you use each day to find out how many days your inhaler will last. Throw away the canister after you have used the labeled number of inhalations even if it still contains some liquid and continues to release a spray when it is pressed. Do not float the canister in water to see if it still contains medication.

Be careful not to get ipratropium into your eyes. If you are using the inhaler, keep your eyes closed when you use the medication. If you are using the nebulizer solution, you should use a nebulizer with a mouthpiece instead of a face mask. If you must use a face mask, ask your doctor how you can prevent the medication from leaking. If you get ipratropium in your eyes, you may develop narrow angle glaucoma (a serious eye condition that may cause loss of vision). If you already have narrow angle glaucoma, your condition may worsen. You may experience widened pupils (black circles in the center of the eyes), eye pain or redness, blurred vision, and vision changes such as seeing halos around lights. Call your doctor if you get ipratropium into your eyes or if you develop these symptoms.

The inhaler that comes with ipratropium aerosol is designed for use only with a canister of ipratropium. Never use it to inhale any other medication, and do not use any other inhaler to inhale ipratropium.

Do not use your ipratropium inhaler when you are near a flame or source of heat. The inhaler may explode if it is exposed to very high temperatures.

Before you use ipratropium inhalation for the first time, read the written instructions that come with it. Ask your doctor or respiratory therapist to show you how to use the inhaler or nebulizer. Practice using the inhaler or nebulizer while he or she watches.

To use the inhaler, follow these steps:

  1. Hold the inhaler with the clear end pointing upward. Place the metal canister inside the clear end of the inhaler. Be sure that it is fully and firmly in place and that the canister is at room temperature.
  2. Remove the protective dust cap from the end of the mouthpiece. If the dust cap was not placed on the mouthpiece, check the mouthpiece for dirt or other objects
  3. If you are using the inhaler for the first time or if you have not used the inhaler in 3 days, prime it by pressing down on the canister to release two sprays into the air, away from your face. Be careful not to spray medication into your eyes while you are priming the inhaler.
  4. Breathe out as completely as possible through your mouth.
  5. Hold the inhaler between your thumb and your next two fingers with the mouthpiece on the bottom, facing you. Place the open end of the mouthpiece into your mouth. Close your lips tightly around the mouthpiece. Close your eyes.
  6. Breathe in slowly and deeply through the mouthpiece. At the same time, press down firmly on the canister.
  7. Hold your breath for 10 seconds. Then remove the inhaler, and breathe out slowly.
  8. If you were told to use two puffs, wait at least 15 seconds and then repeat steps 4 to 7.
  9. Replace the protective cap on the inhaler.

To inhale the solution using a nebulizer, follow these steps;

  1. Twist off the top of one vial of ipratropium solution and squeeze all of the liquid into the nebulizer reservoir.
  2. Connect the nebulizer reservoir to the mouthpiece or face mask.
  3. Connect the nebulizer to the compressor.
  4. Place the mouthpiece in your mouth or put on the face mask. Sit in an upright, comfortable position and turn on the compressor.
  5. Breathe in calmly, deeply, and evenly for about 5 to 15 minutes until mist stops forming in the nebulizer chamber.
  6. Clean your inhaler or nebulizer regularly. Follow the manufacturer's directions carefully and ask your doctor if you have any questions about cleaning your inhaler or nebulizer.

Other uses for this medicine

Ipratropium is also sometimes used to treat the symptoms of asthma. Talk to your doctor about the risks of using this medication for your condition

What special precautions should I follow?

Before using ipratropium inhalation,

  • tell your doctor if you are allergic to ipratropium, atropine, or any other medications.
  • tell your doctor what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: antihistamines; or medications for irritable bowel disease, motion sickness, Parkinson's disease, ulcers, or urinary problems. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
  • if you are using any other inhaled medications, ask your doctor if you should use these medications a certain amount of time before or after you use ipratropium inhalation. If you are using a nebulizer, ask your doctor if you can mix any of your other medications with ipratropium in the nebulizer.
  • tell your doctor if you have or have ever had glaucoma, urinary problems or a prostate  condition.
  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while using ipratropium, consult your doctor.
  • if you will be having surgery, including dental surgery, tell the doctor or dentist that you are using ipratropium.
  • you should know that ipratropium inhalation sometimes causes wheezing and difficulty breathing immediately after it is inhaled. If this happens, consult your doctor right away. Do not use ipratropium inhalation again unless your doctor tells you that you should.

What special dietary instructions should I follow?

Unless your doctor tells you otherwise, continue your normal diet.

What should I do if I forget a dose?

Use the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not use a double dose to make up for a missed one.

What side effects can this medication cause?

Ipratropium may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • dizziness
  • nausea
  • heartburn
  • constipation
  • dry mouth
  • difficulty urinating
  • pain when urinating
  • frequent need to urinate
  • back pain

Some side effects can be serious. If you experience any of the following symptoms, consult your doctor immediately:

  • rash
  • hives
  • itching
  • swelling of the eyes, face, lips, tongue, throat, hands, feet, ankles, or lower legs
  • hoarseness
  • difficulty breathing or swallowing
  • fast or pounding heartbeat
  • chest pain

Ipratropium may cause other side effects. Consult your doctor if you have any unusual problems while using this medication. 

What other information should I know?

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your response to this medicine.

Do not let anyone else use your medication. If you still have symptoms and need further treatment, consult your doctor.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

 Ref. U.S. Natl. Library of Medicine

This information is provided for reference only and not a replacement for and should only be used in conjunction with full consultation with a registered medical practitioner. It may not contain all the available information you require and cannot substitute professional medical care, nor does it take into account all individual circumstances. Although great effort has been made to ensure content accuracy, mph-bd shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise.

Simple Breath Test Might Diagnose Heart Failure An experimental breath test, designed to quickly identify patients suffering from heart failure simply by analyzing the contents of a...
Osteoporosis drug stops Breast cancer growth   News & Events News & Events     HIGHLIGHTS Osteoporosis drug stops growth of breast cancer...
Generic drug safety info loophole FDA plans to close generic drug safety info loophole The US Food and Drug Administration has announced plans to speed up the dissemination of...
Large trials unpublished   News & Events News & Events   HIGHLIGHTS Almost 1 in 3 of large clinical trials unpublished after...
TB activists boo Indian minister News & Events News & Events   HIGHLIGHTS TB activists at world conference boo Indian minister off...
Key bone marrow protein identified News & Events News & Events   HIGHLIGHTS Key bone marrow protein identified as potential new leukemia...